(Press-News.org) PHILADELPHIA, PA (January 14, 2013)—Shutting down a specific pathway in cancer cells appears to improve the ability of common drugs to wipe those cells out, according to new research from scientists at Fox Chase Cancer Center, published in the January issue of Cancer Discovery.
"Ideally, this research will eventually enable scientists to find drugs that disrupt this pathway and boost the impact of current therapies," says Igor Astsaturov, MD, PhD, Attending Physician in the Department of Medical Oncology at Fox Chase. "That's the long-term plan."
The new approach appears to enhance the tumor-killing ability of a commonly prescribed class of drugs that includes cetuximab (Erbitux), used to treat colorectal and head and neck cancers. These drugs work by blocking the activity of the epidermal growth factor receptor (EGFR), which sits on the cell surface and senses cues from the environment, telling cancer cells to grow and divide, says Astsaturov. "The whole mantra of modern day oncology is to suppress these inputs."
Although EGFR inhibitors succeed in killing cancer cells, some malignant cells still find ways to evade the drug, and become resistant to treatment. Consequently, many researchers are actively looking for ways to kill these surviving cancer cells, annihilating tumors completely.
In 2010, Astsaturov and his colleagues identified a pathway in the cell that, when blocked, completely suppressed EGFR activity. Interestingly, the pathway consists of a series of enzymes that, when working in concert, synthesize new molecules of cholesterol, an essential component of the cell wall. This pathway is particularly important to cancer cells, which are constantly dividing and therefore need to produce more cholesterol for the new cells.
Working with cancer cells in the lab, the researchers inactivated a key gene in the cholesterol synthesis pathway, and found the cells became more vulnerable to treatment with cetuximab. The same was true in mice that lacked this particular pathway, says Astsaturov. "Most tumors are only moderately sensitive to inhibitors of EGFR, but when these tumors lack an essential gene in the cholesterol pathway, they become exquisitely sensitive to the anti-EGFR drugs," he says. "The cancers literally melt away in mice."
The researchers then removed one of the cholesterol genes from the mouse genome, and saw that mice developed patchy, scaly skin. When they biopsied this affected skin, they saw no activity of the EGFR protein, reaffirming that shutting down cholesterol synthesis interrupts EGFR. They also observed the same pattern in normal cell lines.
When the cholesterol biosynthesis pathway is blocked, explains Astsaturov, the normal chain of events that creates a cholesterol molecule is interrupted, and cells accumulate intermediate products of cholesterol that block the normal movement of substances around the cell. This cellular traffic jam makes it difficult for the cell to transport important components, such as EGFR, which has to move between the inside of the cell and its surface to function properly. "If you disrupt this traffic, the cancer cells don't survive."
Eventually, says Astsaturov, researchers can design drugs or look for existing ones that block this cholesterol synthesis pathway. For now, his lab is trying to uncover more details of how the pathway works, the role of each protein that is involved—and whether if, by blocking a protein, they can wipe out tumors in humans that evade current therapies. "These proteins represent targets for additional drugs, which could be combined with EGFR inhibitors," he says.
###
Astsaturov's co-authors include Erica A. Golemis, Anna Sukhanova, Andrey Gorin, Ilya G. Serebriiskii, Linara Gabitova, Hui Zheng, Diana Restifo, Tetyana Bagnyukova, Hanqing Liu, Anna Nikonova, Gregory P. Adams, Yan Zhou, Ranee Mehra, Barbara
Burtness, Kathy Q. Cai, Andres Klein-Szanto, and Brian L. Egleston, Fox Chase; David Cunningham and Gail E. Herman, The Research Institute at Nationwide Children's Hospital and the Department of Pediatrics; Lisa E. Kratz, Richard I. Kelley, The Ohio State University; and Louis M. Weiner, Lombardi Comprehensive Cancer Center.
This research was supported in part by NCI grants, the Pennsylvania Tobacco Settlement CURE grant, NIH core grant CA-06927, and the Pew Charitable Fund.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet status for excellence three consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, visit Fox Chase's Web site at www.foxchase.org or call 1-888-FOX CHASE or (1-888-369-2427). END
Scientists find a new way to boost common cancer drugs
Blocking a particular pathway in the cell makes it easier for drugs to annihilate tumors
2013-01-15
ELSE PRESS RELEASES FROM THIS DATE:
Tissue engineers report knee cartilage repair success with new biomaterial
2013-01-15
In a small study, researchers reported increased healthy tissue growth after surgical repair of damaged cartilage if they put a "hydrogel" scaffolding into the wound to support and nourish the healing process. The squishy hydrogel material was implanted in 15 patients during standard microfracture surgery, in which tiny holes are punched in a bone near the injured cartilage. The holes stimulate patients' own specialized stem cells to emerge from bone marrow and grow new cartilage atop the bone.
Results of the study, published in the Jan. 9 issue of Science Translational ...
Graphic warnings on cigarettes effective across demographic groups
2013-01-15
Washington, D.C. – Quitting smoking is a common New Year's resolution for Americans each year, but research has repeatedly shown it is not an easy task. Some groups, such as racial/ethnic minorities, have an even harder time quitting. New research suggests hard-hitting graphic tobacco warnings may help smokers of diverse backgrounds who are struggling to quit. A new study by researchers at Legacy® and Harvard School of Public Health provides further evidence that bold pictorial cigarette warning labels that visually depict the health consequences of smoking — such as those ...
AGU journal highlights -- Jan. 14, 2013
2013-01-15
The following highlights summarize research papers that have been recently published in Geophysical Research Letters (GRL), Journal of Geophysical Research – Oceans (JGR-C), Journal of Geophysical Research-Biogeosciences (JGR-G) and Water Resources Research.
In this release:
1. Seabird activity influences Arctic methane and nitrous oxide emissions
2. U.S. cities less susceptible to water scarcity than previously thought
3. First direct evidence that breaking waves cause horizontal eddies
4. Variability of transparent organic particles in Arctic floodplain lakes
5. ...
Study finds knee replacement surgery may lead to weight gain
2013-01-15
RICHMOND, Va. (Jan. 14, 2013) – Patients who undergo knee replacement surgery may be at risk of gaining more weight than their peers who have not had the surgery, according to a five-year study led by a Virginia Commonwealth University professor.
Daniel Riddle, Ph.D., professor in the VCU Department of Physical Therapy in the School of Allied Health Professions, and his research team reviewed the medical records of nearly 1,000 knee-replacement surgery patients from the Mayo Clinic Health System and found that 30 percent of them gained 5 percent or more of their body ...
If we go over the fiscal cliff, will people spend or save? Childhood environments may hold the key
2013-01-15
In the face of hard times, which strategy gives us the best shot at survival: saving for the future or spending resources on immediate gains? The answer may depend on the economic conditions we faced in childhood, according to new research published in Psychological Science, a journal of the Association for Psychological Science.
Drawing on life history theory, Vladas Griskevicius of the University of Minnesota's Carlson School of Management and colleagues hypothesized that the strategy a person takes when times are tight may be determined, at least in part, by features ...
4,000-year-old shaman's stones discovered near Boquete, Panama
2013-01-15
Archaeologists working at the Smithsonian Tropical Research Institute in Panama have discovered a cluster of 12 unusual stones in the back of a small, prehistoric rock-shelter near the town of Boquete. The cache represents the earliest material evidence of shamanistic practice in lower Central America.
Ruth Dickau, Leverhulme Post-doctoral Fellow at the University of Exeter in England, unearthed the cache of stones in the Casita de Piedra rock-shelter in 2007. A piece of charcoal found directly underneath the cache was radiocarbon dated to 4,800 years ago. A second fragment ...
NIH scientists identify protective role for antibodies in Ebola vaccine study
2013-01-15
WHAT: Researchers at the National Institutes of Health (NIH) and Oregon Health & Science University (OHSU) have found that an experimental vaccine elicits antibodies that can protect nonhuman primates from Ebola virus infection. Ebola virus causes severe hemorrhagic fever in humans and nonhuman primates, meaning that infection may lead to shock, bleeding and multi-organ failure. According to the World Health Organization, Ebola hemorrhagic fever has a fatality rate of up to 90 percent. There is no licensed treatment or vaccine for Ebola virus infection.
Several research ...
Rice researchers see surprising twist to protein misfolding
2013-01-15
An effort to develop software that unravels the complexities of how proteins fold is paying dividends in new findings on how they misfold, according to researchers at Rice University.
The study published this week in the Proceedings of the National Academy of Sciences by chemist Peter Wolynes and his team at Rice's BioScience Research Collaborative should be of particular interest to those who probe the roots of degenerative diseases associated with the aggregation of amyloid fibers in the body. These include Alzheimer's and Parkinson's diseases and Type 2 diabetes.
The ...
Diet may not impact certain health outcomes in older persons
2013-01-15
UNIVERSITY PARK, Pa. -- Eating diets high in sugar and fat may not affect the health outcomes of older adults ages 75 and up, suggesting that placing people of such advanced age on overly restrictive diets to treat their excess weight or other conditions may have little benefit, according to researchers at Penn State and Geisinger Healthcare System.
"Historically people thought of older persons as tiny and frail," said Gordon Jensen, head of the Department of Nutritional Sciences at Penn State, "but that paradigm has changed for many older persons. Currently, 30 percent ...
Will changes in climate wipe out mammals in Arctic and sub-Arctic areas?
2013-01-15
The climate changes depicted by climatologists up to the year 2080 will benefit most mammals that live in northern Europe's Arctic and sub-Arctic land areas today if they are able to reach their new climatic ranges. This is the conclusion drawn by ecologists at Umeå University in a recently published article in the journal Plos ONE.
The scientists Anouschka Hof, Roland Jansson, and Christer Nilsson of the Department of Ecology and Environmental Science at Umeå University investigated how future climate changes may come to impact mammals in northern Europe's Arctic and ...
LAST 30 PRESS RELEASES:
Inability to pay for healthcare reaches record high in U.S.
Science ‘storytelling’ urgently needed amid climate and biodiversity crisis
KAIST Develops Retinal Therapy to Restore Lost Vision
Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response
Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid
Low LDL cholesterol levels linked to reduced risk of dementia
Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients
Almost one in ten people surveyed report having been harmed by the NHS in the last three years
Enhancing light control with complex frequency excitations
New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients
New insight into factors associated with a common disease among dogs and humans
Illuminating single atoms for sustainable propylene production
New study finds Rocky Mountain snow contamination
Study examines lactation in critically ill patients
UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award
Doubling down on metasurfaces
New Cedars-Sinai study shows how specialized diet can improve gut disorders
Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana
PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation
ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy
How VR technology is changing the game for Alzheimer’s disease
A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet
Balance between two competing nerve proteins deters symptoms of autism in mice
Use of antifungals in agriculture may increase resistance in an infectious yeast
Awareness grows of cancer risk from alcohol consumption, survey finds
The experts that can outsmart optical illusions
Pregnancy may reduce long COVID risk
Scientists uncover novel immune mechanism in wheat tandem kinase
Three University of Virginia Engineering faculty elected as AAAS Fellows
Unintentional drug overdoses take a toll across the U.S. unequally, study finds
[Press-News.org] Scientists find a new way to boost common cancer drugsBlocking a particular pathway in the cell makes it easier for drugs to annihilate tumors